GF Fund Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

GF Fund Management’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$10.2K	Buy	343 +26	+8%	+$745	﹤0.01%	543
2026 Q2	$9.5K	Sell	317 -1	-0.3%	-$28	﹤0.01%	540
2026 Q1	$9.5K	Buy	318 +36	+13%	+$1.19K	﹤0.01%	558
2025 Q4	$9.22K	Sell	282 -23	-8%	-$743	﹤0.01%	582
2025 Q3	$10.6K	Sell	305 -52	-15%	-$1.66K	﹤0.01%	550
2025 Q2	$10K	Hold	357	–	–	﹤0.01%	571
2025 Q1	$8.97K	Buy	357 +64	+22%	+$1.62K	﹤0.01%	581
2024 Q4	$8.06K	Buy	+293	New	+$8.17K	﹤0.01%	573

Other funds holding LKFT

Crossmark Global Holdings Houston, Texas $7.69B AUM 31.68% 1-Year Est. Return

Evergreen Capital Management Bellevue, Washington $5.65B AUM 21.62% 1-Year Est. Return

SignatureFD Atlanta, Georgia $7.76B AUM 16.09% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Cacti Asset Management Atlanta, Georgia $1.89B AUM 58.55% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

TD Private Client Wealth New York $5.55B AUM 11.79% 1-Year Est. Return

GF Fund Management's LKFT Position: Q3 2026 in Review

GF Fund Management increased its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 8.2% in Q3 2026, buying an estimated $745 and bringing the position to 343 shares worth $10.2K. The position accounts for ﹤0.01% of the portfolio, ranked #543.

GF Fund Management first reported a position in LKFT in Q4 2024 and has held it in 8 quarters since. The position peaked at $10.6K in Q3 2025. 13 funds tracked by Wall St. Rank hold LKFT as of Q3 2026.

GF Fund Management held 343 shares of Lakefront Biotherapeutics American Depositary Shares worth $10.2K as of Q3 2026.
GF Fund Management bought 26 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2026, an estimated $745.
Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of GF Fund Management's portfolio in Q3 2026, its #543 holding.
GF Fund Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2024 and has held it in 8 quarters since.
GF Fund Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $10.6K in Q3 2025.
13 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2026.

Based on GF Fund Management's 13F filing for Q3 2026, filed 26 Oct 2026.